Risultati di ricerca
16 feb 2023 · The renowned MIT researcher’s latest startup has raised $193 million to develop a new way to shuttle gene-based medicines into the body. Aera Therapeutics emerged from the lab of Feng Zhang, a renowned CRISPR researcher at the Massachusetts Institute of Technology, and is headed by former Alnylam Pharmaceuticals executive Akin Akinc.
Feng Zhang ( China, 1981) es un neurocientífico especializado en optogenética y biología de síntesis, que investiga sobre herramientas de edición del ADN y su aplicación al tratamiento futuro de enfermedades psiquiátricas. Es investigador del Instituto McGovern para Investigación del Cerebro, dependiente del Instituto de Tecnología de ...
3 gen 2013 · Feng Zhang † [email protected] Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA, and McGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.
12 ott 2021 · Feng Zhang discusses the expanding gene-editing toolkit, the need for better delivery systems and the reprogrammable biological technologies that remain to be discovered.
6 nov 2015 · Feng Zhang at the Broad Institute in Cambridge, Mass. Katherine Taylor for STAT Life might be programmable In Des Moines, middle-school biology class meant dissecting frogs stinking of formaldehyde.
28 giu 2023 · A team of researchers led by Feng Zhang at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard has uncovered the first programmable RNA-guided system in eukaryotes — organisms that include fungi, plants, and animals.
Research Summary. Feng Zhang, the W. M. Keck Career Development Associate Professor in Biomedical Engineering, is a bioengineer focused on developing tools to better understand nervous system function and disease. He has pioneered the development of genome editing tools for use in eukaryotic cells -- including human cells -- from natural ...
